Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy-Reference-Cited by-同舟云学术

Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy

Published:2024-06-19 Issue:8 Volume:73 Page:1393-1409
ISSN:1023-3830
Container-title:Inflammation Research
language:en
Short-container-title:Inflamm. Res.

Author:

Zhang Yuan,Zhang Cong,He Jing,Lai Guichuan,Li Wenlong,Zeng Haijiao,Zhong Xiaoni,Xie Biao

Funder

Chongqing Postgraduate Scientific Research and Innovation Project in 2023

National Youth Science Foundation Project

Science and Technology Research Program

Chongqing Maternal and Child Disease Prevention and Control and Public Health Research Center Open Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00011-024-01905-5.pdf

Reference75 articles.

1. Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34.

2. Pitcovski J, Shahar E, Aizenshtein E, Gorodetsky R. Melanoma antigens and related immunological markers. Crit Rev Oncol Hematol. 2017;115:36–49.

3. Maida I, Zanna P, Guida S, et al. Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α. J Transl Med. 2019;17(1):20.

4. Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global Burden of Cutaneous Melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495–503.

5. Li M, Long X, Bu W, Zhang G, Deng G, Liu Y, et al. Immune-related risk score: an immune-cell-pair-based prognostic model for cutaneous melanoma. Front Immunol. 2023;14:1112181.